Key result
Only ~20% of patients prescribed chronic antipsychotics receive standard yearly cardiometabolic monitoring.
Why the study?
Antipsychotics carry significant cardiometabolic adverse event profiles, but adherence to routine guideline-recommended monitoring in primary care is known to be suboptimal.
Are patients prescribed chronic antipsychotic therapy in primary care receiving adequate cardiometabolic monitoring according to guidelines?
Population
497 patients with mental disorders prescribed antipsychotics at two general practices in England
Comparison
Patient-related factors and drug characteristics predicting cardiometabolic monitoring
Design
Retrospective observational study
Authors
Loading...
Suboptimal monitoring in primary care may warrant quality improvement; leaves open whether interventions boost guideline adherence in antipsychotic users.
Observational (n=497)
Yes
Are patients prescribed chronic antipsychotic therapy in primary care receiving adequate cardiometabolic monitoring according to guidelines?
Routine cardiometabolic monitoring for primary care patients on antipsychotics is infrequent and fails to meet guideline recommendations, particularly for glucose and comprehensive lipid profiles.
Ali et al. (2023) conducted an observational in Mental disorders prescribed antipsychotics (n=497). Chronic antipsychotic therapy was evaluated on Proportion of patients with evidence of monitoring for cardiometabolic parameters at least once yearly. Routine cardiometabolic monitoring for patients prescribed antipsychotics was suboptimal, with standard yearly monitoring achieved in only approximately 20% of patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: